Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (referred to as "Therapix" or the "Company") covers the month of August 2020, with the report dated August 20, 2020. The filing details a court-approved settlement with Pure Capital Ltd. that resulted in a complete replacement of the Company's board of directors and the appointment of new executive officers.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The primary financial disclosure relates to a settlement agreement wherein Pure Capital Ltd. agreed to deposit $1,500,000 with a temporary trustee nominated by the Tel Aviv-Jaffa District Court. These funds are designated to cover and pay the Company's debts as approved under the settlement procedures.
Material Changes
- Board and Executive Restructuring: The entire board of directors was replaced following the execution of the $1.5 million deposit. New directors include Itschak Shrem, Amitay Weiss, Moshe Revach, Lior Amit, Lior Vider, and Liat Sidi.
- Leadership Appointments: Itschak Shrem was appointed Chairman of the Board, and Amitay Weiss was appointed Chief Executive Officer.
- Shareholder Meeting Ratification: The new board nullified the previous reliance on discretionary voting by the depositary bank for the August 4, 2020, shareholder meeting, deeming it a violation of applicable law. The results were recalculated based on actual votes, leading to the approval of proposals 2, 3, 4, and 8, while proposals 1, 5, 6, and 7 were not approved.
- Creditor Claims Process: A formal process was established for creditors to file proofs of claim with the Trustee within 21 days of the filing date.
Outlook, Risks, and Contingencies
The filing outlines a structured contingency plan for debt resolution. Creditors have 21 days to file claims. The Trustee must decide on the validity of claims within 14 days of submission (and no later than 30 days after the claim period closes). Valid claims must be paid within 7 days of the Trustee's decision. Both the Company and creditors retain the right to appeal the Trustee's decision to the Court within 15 days. The filing notes that the settlement does not derogate from any other creditor's rights towards the Company.
Investor Verification Checklist
- Verify the status of the $1,500,000 deposit made by Pure Capital Ltd. with the temporary trustee.
- Confirm the final list of approved and rejected shareholder proposals from the August 4, 2020, meeting following the recalculation.
- Monitor the volume and validity of creditor claims filed within the 21-day window to assess the Company's remaining debt obligations.
- Review the biographies and potential conflicts of interest of the newly appointed board members, particularly those with ties to other public companies or government entities.
- Check for any subsequent filings regarding appeals of the Trustee's decisions on creditor claims.